Go Pro
NASDAQ:AIFC

ALT5 Sigma Q3 2025 Earnings Report

ALT5 Sigma logo
$0.43 -0.03 (-7.38%)
As of 07/24/2026 04:00 PM Eastern

ALT5 Sigma EPS Results

Actual EPS
$0.29
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

ALT5 Sigma Revenue Results

Actual Revenue
$7.58 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

ALT5 Sigma Announcement Details

Quarter
Q3 2025
Time
N/A
Conference Call Date
Monday, January 12, 2026
Conference Call Time
7:00AM ET

ALT5 Sigma Earnings Headlines

ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel
See More ALT5 Sigma Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ALT5 Sigma? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ALT5 Sigma and other key companies, straight to your email.

About ALT5 Sigma

ALT5 Sigma (NASDAQ:AIFC) Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments. The Biotechnology segment focuses on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Recycling segment is involved in a turnkey appliance recycling program. The company was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV.

View ALT5 Sigma Profile